Study of upadacitinib for teens with severe hair loss
Treatments studied
Part of Skin clinical trials.
This study tests if upadacitinib can help young people with severe alopecia areata (a condition causing patchy hair loss) regrow their hair. It may be an option if hair loss has been present for less than 8 years and there has been no recent improvement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a child or teenager (under 18 years old)
- You have severe hair loss from alopecia areata (at least 50% of scalp hair missing)
- Your hair has not regrown on its own in the last 6 months
- Your current hair loss episode started less than 8 years ago
- You do not have other types of hair loss or scalp conditions that could affect the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called ritlecitinib for children with severe alopecia areata (a condition causing hair loss). It is for kids who have already completed a previous study of this medicine to see how well it works and how safe it is over a longer period.
This study tests an oral medication (SYHX1901) for severe alopecia areata, a condition where the immune system attacks hair follicles, causing significant hair loss. If you qualify, you may receive the study drug to see if it helps regrow hair and improve your condition.
This study tests if the medicine ritlecitinib can help regrow hair in people with alopecia areata, a condition that causes patchy hair loss. It's for young people and adults who have lost between 20% and 50% of their scalp hair for at least 6 months but no more than 10 years.
This trial studies dupilumab (an injection medicine) to help grow hair in children and teens with alopecia areata, an autoimmune hair-loss condition. It aims to see whether the treatment improves hair regrowth compared with usual care over the study period.
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
This study tests an investigational oral medication (deuruxolitinib) for adolescents with severe alopecia areata (hair loss). It aims to see if it can help hair regrow safely.
Hear when a new Severe Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.